Condition
Obese
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 225 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownA Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese AdultsNCT07363148 · 2026-08-05
RECRUITINGMechanical Ventilation in Obese Surgical PatientsNCT07774065 · 2026-07-29
RECRUITINGEffect of Combined Resisted Training and Protein-based Diet on Frailty in Sarcopenic Elderly WomenNCT07627919 · 2026-06-30
RECRUITINGTrans-nasal Endoscopy for Bariatric PatientsNCT06200961 · 2026-04-20
RECRUITINGA Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or ObeseNCT07411560 · 2026-02-09
RECRUITINGA Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese ParticipantsNCT07219589 · 2025-11-06
RECRUITINGRole of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary SyndromeNCT05819853 · 2023-11-03
RECRUITINGExercise Response in Humans With ObesityNCT05857150 · 2023-09-22
RECRUITINGTaxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)NCT05770570 · 2022-12-22
RECRUITINGAdipose Inflammation and Diabetes (FAB)NCT04255264 · 2019-08-01
RECRUITINGDynamo: a Tailored Lifestyle Promotion Intervention Among Pediatric Patients With Cardiometabolic Risk FactorsNCT01736748 · 2012-08-01
RECRUITINGLongitudinal Changes in Lower Extremity Alignment and Mechanical Axis Parameters After Bariatric Surgery in Patients With Morbid Obesity: A Prospective Observational StudyNCT07794566 · 2026-09-07
ACTIVE_NOT_RECRUITINGDietary Sugar Absorptive Phenotype for Prediction of Weight Loss OutcomeNCT05408728 · 2026-07-01
ENROLLING_BY_INVITATIONA Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy ParticipantsNCT07559240 · 2026-05-15
NOT_YET_RECRUITINGA Study of SA030 Injection in Overweight or Obese ParticipantsNCT07479862 · 2026-04-16
NOT_YET_RECRUITINGStudy to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes MellitusNCT07205900 · 2025-12-02
ACTIVE_NOT_RECRUITINGAleniglipron Phase 2 in Type 2 Diabetes MellitusNCT07400588 · 2025-12-01
ACTIVE_NOT_RECRUITINGThe Study of [14C] GZR18NCT07119450 · 2025-05-07
COMPLETEDEmpowering Healthy Lifestyle Behavior to Prevent and Control Obesity in Young AdultsNCT06943651 · 2025-04-21
NOT_YET_RECRUITINGPilates Mat Exercises Training on Functional Performance in Middle Age Obese WomenNCT06779383 · 2025-01-20
NOT_YET_RECRUITINGDriving Pressure-guided Positive End-expiratory Pressure to Prevent Postoperative Atelectasis in Obese Children: a Prospective, Randomized Controlled Clinical TrialNCT06471491 · 2024-09-11
COMPLETEDDiet Intervention on Obesity Related ComplicationNCT06719466 · 2024-09-01
ACTIVE_NOT_RECRUITINGValidity and Reliability of the 6-minute Pegboard Ring Test in Obese IndividualsNCT06590584 · 2024-08-01
UNKNOWNA Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or OverweightNCT06440980 · 2024-06-24
COMPLETEDThe Effect of Mask Combined With High Flow Oxygen on Preoxygenation During Induction of General Anesthesia in Obese PatientsNCT06562660 · 2024-05-01
UNKNOWNEfficacy of Henagliflozin for Weight Loss in Obesity Without DiabetesNCT06216340 · 2024-02-15
UNKNOWNStudy of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory IssuesNCT06171152 · 2024-01-26
SUSPENDEDA Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese ParticipantsNCT06186622 · 2024-01-02
COMPLETEDRelation Between Forward Head Posture and Incidence of Headache in Obese AdultsNCT06383429 · 2024-01-01
COMPLETEDEvaluating of the Impact of a Connected and Non-intrusive Device in Improving the Screening of Sleep Apnea Syndrome and the Addressing of Potentially Pathological Patients in Hospital EnvironmentNCT06141967 · 2023-11-30
COMPLETEDAminophylline on Perioperative Lung Mechanics in COPD Morbidly Obese Patients Undergoing Laparoscopic Bariatric SurgeryNCT06125665 · 2023-11-11
UNKNOWNVolume-Controlled Ventilation and Pressure-Controlled Ventilation Volume Guaranteed in Obese Patients in Laparoscopic-Assisted SurgeryNCT06117748 · 2023-11-05
UNKNOWNUmbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade InflammationNCT06448052 · 2023-11-01
ACTIVE_NOT_RECRUITINGA Study of CT-868 in Type 1 Diabetes MellitusNCT06062069 · 2023-10-19
COMPLETEDGastric Insufflation During Facemask Ventilation at Different Levels of End-expiratory Pressure in Obese PatientsNCT05979129 · 2023-08-06
COMPLETEDEvaluation of the Colonization Capacity of a Probiotic Bacterium.NCT05878444 · 2023-06-01
UNKNOWNThe Safety, Tolerability and Pharmacokinetic Study of RAY1225NCT05835752 · 2023-05-18
COMPLETEDEffects of Aerobic Exercise on Basic Metabolic Panel Perceived Exertion and Exercise Adherence in ElderlyNCT05865145 · 2023-05-01
UNKNOWNA Multiple Dose Study of LY3502970 in Healthy Overweight and Obese ParticipantsNCT05841238 · 2023-04-26
COMPLETEDThe Effects of the GOLO for Life® Plan and Release Supplement on Weight Management in Overweight and Obese AdultsNCT05844631 · 2023-04-20
COMPLETEDThe Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 DiabetesNCT05844644 · 2023-04-20
UNKNOWNEffects of Adding L-BAIBA or L-BAIBA + Grains of Paradise to Exercising Adult Overweight and Obese Men and WomenNCT05775003 · 2023-04-11
COMPLETEDGetHealthy-OA: A Program to Improve Pain and Function for Patients With Knee Osteoarthritis, Obesity, and DepressionNCT05482672 · 2023-04-01
WITHDRAWNComparative Effects of Using Black Seed and Cumin Seed on BCP of Obese Grade INCT05770791 · 2023-01-27
UNKNOWNSafety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or ObeseNCT05616013 · 2022-11-16
COMPLETEDA Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy ParticipantsNCT05613387 · 2022-11-07
COMPLETEDA Study of Distal Jejunal-release Dextrose in Obese ParticipantsNCT05385978 · 2022-11-01
ACTIVE_NOT_RECRUITINGConventional Palpation Versus Ultrasound Assisted Spinal Anesthesia in ObstetricsNCT05846100 · 2022-11-01
UNKNOWNAcupuncture for Impaired Glucose Tolerance in Overweight/Obese PopulationNCT05347030 · 2022-10-06
UNKNOWNSafety and Pharmacokinetics of HU6NCT05433506 · 2022-09-15
COMPLETEDEffect of Resistance Training on Energy Intake and Appetite Regulation, 12-weeks Resistance TrainingNCT05530629 · 2022-08-20
UNKNOWNActive Communities - Adherence to Physical ActivityNCT05493345 · 2022-08-05
UNKNOWNDetermination of the Validity of One-Minute Sit-to-Stand Test in Obese and Overweight Children and AdolescentsNCT05392920 · 2022-07-08
UNKNOWNResponse of Gut Microbiota and Cardiometabolic Biomarkers to Consumption of WalnutsNCT04307628 · 2022-06-01
WITHDRAWNA Study of LY3502970 in Healthy Overweight and Obese ParticipantsNCT05313802 · 2022-05-26
COMPLETEDWeight Management Plus Megestrol Acetate in Early-stage Endometrioid CarcinomaNCT05316467 · 2022-05-01
TERMINATEDThe Effectiveness of Intermittent Fasting and Behavioral Economics Intervention on Weight Control in Obese PatientsNCT06261229 · 2022-04-18
UNKNOWNMetabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B PatientsNCT07175688 · 2022-04-10
COMPLETEDDose of Magnesium Sulfate Infusion in ObeseNCT04645719 · 2022-04-01
UNKNOWNDoes BMI Influence Pain Follow vNOTE SurgeryNCT05230407 · 2022-02-05
COMPLETEDCommon interventions
PlaceboDRUG12PlaceboDIETARY_SUPPLEMENT7PlaceboOTHER4Usual CareBEHAVIORAL4DexmedetomidineDRUG2Enhanced Usual CareBEHAVIORAL2Exercise InterventionOTHER2Fat BiopsyPROCEDURE2LiraglutideDRUG2LY3502970DRUG2OrforglipronDRUG2PioglitazoneDRUG2ReleaseDIETARY_SUPPLEMENT2WebsiteBEHAVIORAL2[7,7,8,8-2H]-palmitateOTHER16P interventionBEHAVIORAL1Abdominal UltrasoundDEVICE1AcetaminophenDRUG1Active ComparatorDIETARY_SUPPLEMENT1AcupunctureOTHER1Acute FastingOTHER1Aerobic exerciseOTHER1Aerobic Exercise TrainingBEHAVIORAL1Aerobic exercise training GroupOTHER1AleniglipronDRUG1
Leading sponsors
Mayo Clinic
9
Eli Lilly and Company
5
Massachusetts General Hospital
5
Milton S. Hershey Medical Center
3
Philip Kern
3
University of California, Davis
3
University of California, Los Angeles
3
University of California, San Diego
3
Aphaia Pharma US LLC
2
Arkansas Children's Hospital Research Institute
2
Clinical Nutrition Research Center, Illinois Institute of Technology
2
Golo
2
Hanmi Pharmaceutical Company Limited
2
Henan Provincial People's Hospital
2
Kaiser Permanente
2
Trial status mix
COMPLETED153
UNKNOWN30
RECRUITING11
ACTIVE_NOT_RECRUITING10
WITHDRAWN8
TERMINATED7
NOT_YET_RECRUITING4
ENROLLING_BY_INVITATION1
SUSPENDED1
Phase mix
NA123
PHASE127
PHASE227
PHASE312
PHASE48
EARLY_PHASE14
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.